In order to elucidate the mechanism by which genes and their variants affect disease development, human induced pluripotent stem cells (hiPSC) have been used to establish a PNPLA3-related NAFLD model. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.